Transapical transcatheter aortic valve implantation for predominant aortic regurgitation with a self-expandable valve

BACKGROUND: Transcatheter aortic valve implantation (TAVI) has become the gold standard for high-risk severe aortic stenosis. However, the experience of treating aortic regurgitation (AR) with this technology is still limited. Previously, we have demonstrated excellent 1-year outcomes of transapical...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Huan, Liu, Shun, Lu, Yuntao, Yang, Ye, Wang, Wenshuo, Zhu, Liming, Wei, Lai, Wang, Chunsheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139073/
https://www.ncbi.nlm.nih.gov/pubmed/32274119
http://dx.doi.org/10.21037/jtd.2020.01.04

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7139073/
https://www.ncbi.nlm.nih.gov/pubmed/32274119
http://dx.doi.org/10.21037/jtd.2020.01.04

Ejemplares similares